Cannae (NYSE:CNNE – Get Free Report) and Lesaka Technologies (NASDAQ:LSAK – Get Free Report) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk and analyst recommendations.
Institutional & Insider Ownership
88.1% of Cannae shares are owned by institutional investors. Comparatively, 24.2% of Lesaka Technologies shares are owned by institutional investors. 10.9% of Cannae shares are owned by company insiders. Comparatively, 6.0% of Lesaka Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares Cannae and Lesaka Technologies”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Cannae | $423.60 million | 1.67 | -$513.20 million | ($3.02) | -5.40 |
| Lesaka Technologies | $721.55 million | 0.48 | $2.76 million | $0.04 | 101.75 |
Lesaka Technologies has higher revenue and earnings than Cannae. Cannae is trading at a lower price-to-earnings ratio than Lesaka Technologies, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Cannae has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500. Comparatively, Lesaka Technologies has a beta of 0.36, meaning that its share price is 64% less volatile than the S&P 500.
Analyst Ratings
This is a summary of recent recommendations for Cannae and Lesaka Technologies, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Cannae | 1 | 0 | 2 | 0 | 2.33 |
| Lesaka Technologies | 0 | 2 | 0 | 1 | 2.67 |
Cannae presently has a consensus price target of $17.00, indicating a potential upside of 4.21%. Lesaka Technologies has a consensus price target of $7.56, indicating a potential upside of 85.75%. Given Lesaka Technologies’ stronger consensus rating and higher possible upside, analysts plainly believe Lesaka Technologies is more favorable than Cannae.
Profitability
This table compares Cannae and Lesaka Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Cannae | -38.18% | -14.10% | -10.60% |
| Lesaka Technologies | 0.43% | 1.65% | 0.46% |
Summary
Lesaka Technologies beats Cannae on 10 of the 15 factors compared between the two stocks.
About Cannae
Cannae Holdings, Inc. is a principal investment firm. The firm primarily invests in restaurants, technology enabled healthcare services, financial services and more. It takes both minority and majority stakes. Cannae Holdings, Inc. was founded in 2014 and is based in Las Vegas, Nevada.
About Lesaka Technologies
Lesaka Technologies, Inc. operates as a Fintech company that utilizes its proprietary banking and payment technologies to deliver financial services solutions to merchants (B2B) and consumers (B2C) in Southern Africa. It offers cash management solutions, growth capital, card acquiring, bill payment technologies, and value-added services to formal and informal retail merchants, as well as banking, lending, and insurance solutions to consumers across Southern Africa. The company also engages in the sale of POS devices, SIM cards, and other consumables; and license of rights to use certain technology developed by the company, as well as offers related technology services. The company was formerly known as Net 1 UEPS Technologies, Inc. and changed its name to Lesaka Technologies, Inc. in May 2022. Lesaka Technologies, Inc. was incorporated in 1997 and is headquartered in Johannesburg, South Africa.
Receive News & Ratings for Cannae Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannae and related companies with MarketBeat.com's FREE daily email newsletter.
